These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 14836691)

  • 1. [Clinical use, indications and effect of irgapyrine].
    LASCH F; MORITZ E; NOWAK O
    Wien Med Wochenschr; 1951 Mar; 101(12):214-7. PubMed ID: 14836691
    [No Abstract]   [Full Text] [Related]  

  • 2. [Irgapyrine in the ambulatory therapy of rheumatism].
    ZAIONTZ
    Med Hyg (Geneve); 1951 Feb; 9(187 Spec. No.):60. PubMed ID: 14805484
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic results with the pyrazolone derivative irgapyrine].
    DE WIT JC
    Geneeskd Gids; 1952 Dec; 30(26):566-71. PubMed ID: 13043841
    [No Abstract]   [Full Text] [Related]  

  • 4. [Irgapyrine in rheumatic diseases].
    SELIGER H
    Arztl Wochensch; 1951 Jan; 6(4):89-90. PubMed ID: 14810633
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experience with an association of pyrazolone derivatives in the treatment of focal rheumatism and dystrophic rheumatism].
    MORANDI GA
    Minerva Med; 1962 Jan; 53():226-9. PubMed ID: 14475801
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of rheumatism with tomanol, a new pyrazolone-pyrazolidine preparation].
    SCHMID J
    Munch Med Wochenschr; 1959 Oct; 101():1746-50. PubMed ID: 14442977
    [No Abstract]   [Full Text] [Related]  

  • 7. [Intramuscular pyrazolone therapy of the rheumatic diseases].
    LODING H
    Med Klin; 1953 Nov; 48(47):1747-9. PubMed ID: 13110710
    [No Abstract]   [Full Text] [Related]  

  • 8. [G 15903, irgapyrin, as an analgesic and antiphlogistic].
    TROMPIZ G
    Ther Umsch Med Bibliogr; 1950 Oct; 7(7):112-4. PubMed ID: 14787969
    [No Abstract]   [Full Text] [Related]  

  • 9. [Irgapyrine therapy from the standpoint of the practician].
    GENEWEIN C
    Praxis; 1951 Apr; 40(17):349-51. PubMed ID: 14843995
    [No Abstract]   [Full Text] [Related]  

  • 10. [Rheumatism and the nervous system; meningeal reactions in rheumatism; clinical aspects].
    SCHEIFFARTH F
    Z Rheumaforsch; 1950 Apr; 9(3-4):93-133. PubMed ID: 15431896
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical observations on the use of 4-nicotinamido-1, 5-dimethyl-2-phenyl-3-pyrazolone as analgesic and antirheumatic agent].
    PARRAVICINI M; MODESTI P
    Policlinico Prat; 1959 Oct; 66():1456-60. PubMed ID: 13854239
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on anti-rheumatic efficacy of irgapyrine].
    SERRA-PERALBA A; ANGENAULT C; DE DALMASES R
    Prensa Med Argent; 1952 Feb; 39(9):399-404. PubMed ID: 14929882
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of childhood rheumatism with irgapyrine].
    HOCKERTS T
    Dtsch Med Wochenschr; 1953 May; 78(18):669-70. PubMed ID: 13067956
    [No Abstract]   [Full Text] [Related]  

  • 14. [Certain nervous system changes in children with rheumatism].
    IL'IASH K
    Pediatriia; 1958 Sep; 23(9):36-42. PubMed ID: 13613895
    [No Abstract]   [Full Text] [Related]  

  • 15. [Rheumatic complications of the nervous system].
    HOFF H
    Wien Klin Wochenschr; 1951 Jul; 63(27):488-93. PubMed ID: 14867305
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical date on irgapyrine].
    STEINER FJ
    Ned Tijdschr Geneeskd; 1953 Apr; 97(16):993-8. PubMed ID: 13072677
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of pyramidon preparation, particularly irgapyrine].
    FELLINGER K; FERSTL A; LEON-HARTSBERGER F; SCHMID J
    Med Klin; 1951 Sep; 46(37):976-80. PubMed ID: 14882030
    [No Abstract]   [Full Text] [Related]  

  • 18. [Essay with associated investigations of the nervous system in primary chronic rheumatism].
    KOZLOWSKA F; SZERESZEWSKA H; WENDER M
    Pol Arch Med Wewn; 1956; 26(5):737-50. PubMed ID: 13388879
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimental and clinical studies on irgapyrine. II. Clinical experiences with irgapyrine].
    SEIDEL K; KNOBLOCH H
    Munch Med Wochenschr; 1954 Jan; 96(4):84-7; contd. PubMed ID: 13144724
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of rheumatic diseases and degenerative joint diseases with 4-(N-nicotinoylaminoacetylamino)-1-phenyl-2,3-dimethyl-pyrazolone-(5) HCl].
    DZIUBA K
    Arzneimittelforschung; 1961 Nov; 11():1049-51. PubMed ID: 13888918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.